Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ron Goeree

Showing results (111-120 of 185) with videos related to

Pageof 19
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2011
Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluationRon Goeree, Rob Hopkins, John K Marshall, et al.
Heart Rhythm|April 27, 2005
Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic PacingBernie J O'Brien, Gordon Blackhouse, Ron Goeree, et al.
Pharmacoeconomics|July 6, 2016
BEACON: A Summary Framework to Overcome Potential Reimbursement HurdlesWilliam C N Dunlop, C Daniel Mullins, Olaf Pirk, et al.
Hospital Practice (1995)|April 29, 2014
Time and labor costs associated with administration of intravenous bisphosphonates for breast or prostate cancer patients with metastatic bone disease: a time and motion studyFeng Xie, Robert B Hopkins, Natasha Burke, et al.
Health Economics|February 3, 2005
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysisAndrew R Willan, Eleanor M Pinto, Bernie J O'Brien, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 19, 2008
Cost-effectiveness of reducing wait times for cataract surgery in OntarioRobert B Hopkins, Jean-Eric Tarride, James Bowen, et al.
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|June 21, 2011
Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysisKathryn Gaebel, Gord Blackhouse, Kaitryn Campbell, et al.
International Journal of Technology Assessment in Health Care|July 19, 2013
Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysisDaria O'Reilly, Anjori Pasricha, Kaitryn Campbell, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 1, 2011
Using health technology assessment to support evidence-based decision-making in Canada: an academic perspectiveFeng Xie, James M Bowen, Simone C Sutherland, et al.
Clinical Therapeutics|June 23, 2009
Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpuraFeng Xie, Gord Blackhouse, Nazila Assasi, et al.
Pageof 19

Showing results (111-120 of 185) with videos related to

Sort By:
Pageof 19
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2011
Cost-utility of laparoscopic Nissen fundoplication versus proton pump inhibitors for chronic and controlled gastroesophageal reflux disease: a 3-year prospective randomized controlled trial and economic evaluationRon Goeree, Rob Hopkins, John K Marshall, et al.
Heart Rhythm|April 27, 2005
Cost-effectiveness of physiologic pacing: results of the Canadian Health Economic Assessment of Physiologic PacingBernie J O'Brien, Gordon Blackhouse, Ron Goeree, et al.
Pharmacoeconomics|July 6, 2016
BEACON: A Summary Framework to Overcome Potential Reimbursement HurdlesWilliam C N Dunlop, C Daniel Mullins, Olaf Pirk, et al.
Hospital Practice (1995)|April 29, 2014
Time and labor costs associated with administration of intravenous bisphosphonates for breast or prostate cancer patients with metastatic bone disease: a time and motion studyFeng Xie, Robert B Hopkins, Natasha Burke, et al.
Health Economics|February 3, 2005
Country specific cost comparisons from multinational clinical trials using empirical Bayesian shrinkage estimation: the Canadian ASSENT-3 economic analysisAndrew R Willan, Eleanor M Pinto, Bernie J O'Brien, et al.
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|March 19, 2008
Cost-effectiveness of reducing wait times for cataract surgery in OntarioRobert B Hopkins, Jean-Eric Tarride, James Bowen, et al.
Open Medicine : a Peer-Reviewed, Independent, Open-Access Journal|June 21, 2011
Intravenous immunoglobulin for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review and meta-analysisKathryn Gaebel, Gord Blackhouse, Kaitryn Campbell, et al.
International Journal of Technology Assessment in Health Care|July 19, 2013
Hyperbaric oxygen therapy for diabetic ulcers: systematic review and meta-analysisDaria O'Reilly, Anjori Pasricha, Kaitryn Campbell, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 1, 2011
Using health technology assessment to support evidence-based decision-making in Canada: an academic perspectiveFeng Xie, James M Bowen, Simone C Sutherland, et al.
Clinical Therapeutics|June 23, 2009
Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpuraFeng Xie, Gord Blackhouse, Nazila Assasi, et al.
Pageof 19